Ghent, Belgium, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA (the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in ...
, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Ghent, Belgium - 14 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback